Crossmark

Mechanistic insights into the hepatoprotective role of rabeprazole against cyclophosphamide-induced hepatotoxicity via AMPK/SIRT1 activation and suppression of TLR4/NF-κB and MAPK pathways

Crossref DOI link: https://doi.org/10.1007/s00210-025-04577-y

Published Online: 2025-09-11

Published Print: 2026-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Saleh, Asmaa

Raslan, Nahed A.

Selim, Heba Mohammed Refat M.

Ibrahim, Samar

Farghly, Ahmed Mohamed

Shalkami, Abdel-Gawad S.

Salama, Lamiaa A.

Elhusseiny, Shaza M.

Hafez, Shaimaa M.

Mahmoud, Nihal A.

Alwakeel, Asmaa I.

Ali, Shimaa O.

Elsabbagh, Sherif A.

Fouda, Manar Seleem

El-Dessouki, Ahmed M.
License Information

Text and Data Mining valid from 2025-09-11

Version of Record valid from 2025-09-11
More Information

Article History

Received: 24 July 2025

Accepted: 21 August 2025

First Online: 11 September 2025

Declarations

:

: All procedures complied with institutional and NIH guidelines (Publication No. 85-23, amended 1985) and obtained approval from the Ethics Committee of the Faculty of Pharmacy (REC1125).

: This is not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below